Table 7.
Scenario analyses varying the model parameters
| Life years | QALYs | Total costs (€) | ICER (€/LY) | ICER (€/QALY) | |
|---|---|---|---|---|---|
| Base case | |||||
| SCAD | 6.03 | 4.41 | 35,177 | ||
| SC | 5.11 | 3.75 | 30,932 | 4579 | 6491 |
| Difference | 0.93 | 0.65 | 4245 | ||
| Five-year time-horizon | |||||
| SCAD | 4.03 | 2.92 | 21,290 | ||
| SC | 3.58 | 2.61 | 21,372 | SCAD | Dominant |
| Difference | 0.45 | 0.31 | -82 | ||
| Lifetime time-horizon | |||||
| SCAD | 7.49 | 5.51 | 45,451 | ||
| SC | 6.22 | 4.60 | 38,055 | 5841 | 8151 |
| Difference | 1.27 | 0.91 | 7396 | ||
| All patients previously hospitalised at model entry | |||||
| SCAD | 5.79 | 4.23 | 36,527 | ||
| SC | 4.73 | 3.47 | 32,679 | 3609 | 5082 |
| Difference | 1.07 | 0.76 | 3848 | ||
| SCAD participation for 10 years | |||||
| SCAD | 6.29 | 4.59 | 39,023 | ||
| SC | 5.11 | 3.75 | 30,932 | 6829 | 9680 |
| Difference | 1.18 | 0.84 | 8095 | ||
ICER incremental cost-effectiveness ratio; LY life-years; QALY quality-adjusted life year; SC standard care; SCAD Suivi Clinique A Domicile